FDA Approves Sanofi's Sarclisa Escena as First Anticancer Drug Delivered via Wearable On-Body Injector
The FDA cleared a subcutaneous, wearable-device formulation of Sanofi's multiple myeloma drug Sarclisa, the first cancer therapy approved for on-body injector delivery.